Knowledge Base

Research Articles

Explore our collection of in-depth research articles, literature reviews, and educational guides on peptide science.

88 articlesPage 2 of 10
Filter:All ArticlesHealing & RecoveryGrowth HormoneCognitive EnhancementMetabolic PeptidesAntimicrobial Peptides+11 more
Research14 min

CagriSema: The Amylin-GLP-1 Combo That Could Change the Weight Loss War

Novo Nordisk's CagriSema pairs an amylin analog with semaglutide to attack appetite from two directions at once. With 22.7% weight loss in Phase 3, an FDA filing already submitted, and a dramatic head-to-head showdown against tirzepatide, here's what the clinical data actually shows.

Metabolic Peptides
Research15 min

Survodutide and MASH: The Dual Agonist Taking Aim at the Liver Disease Epidemic

With up to 62% of patients achieving MASH resolution in Phase 2 trials—roughly double the only approved drug—Boehringer Ingelheim's GLP-1/glucagon dual agonist could reshape how we treat the world's most common liver disease. Here's what the data shows.

Metabolic Peptides
Research16 min

AI-Driven Peptide Discovery: How Machine Learning Is Redesigning the Drug Pipeline

From generative models designing antimicrobial peptides in hours to the first AI-designed peptide entering human clinical trials, artificial intelligence is fundamentally reshaping how peptide therapeutics are discovered, optimized, and brought to patients.

Peptide Education
Research16 min

Retatrutide: The Triple Agonist That's Rewriting the Weight Loss Playbook

With nearly 29% average weight loss in trials—double what Ozempic delivers—Eli Lilly's triple hormone agonist is generating massive buzz. Here's what the science actually shows, when it might be available, and what those online discussions aren't telling you.

Metabolic Peptides
Research14 min

GLP-1 and Addiction: Can Ozempic Really Cure Your Cravings?

Thousands of patients report losing interest in alcohol, gambling, and even shopping after starting GLP-1 drugs. The science behind these claims is both promising and complicated—and it's reshaping how we think about addiction.

Metabolic Peptides
Research12 min

Personalized Neoantigen Peptide Vaccines: The Future of Cancer Immunotherapy

Personalized cancer vaccines using tumor-specific peptide neoantigens represent one of the most promising frontiers in oncology. With Phase 1 trials showing 5-year survival data and no recurrences in high-risk patients, this emerging technology is transforming our approach to treating cancer.

Immune Modulation
Research14 min

GLP-1 and Brain Health: What the EVOKE Trial Failure Actually Tells Us

The EVOKE trials failed to show semaglutide slows Alzheimer's progression. Headlines called it a setback. But the full story is more nuanced—and more interesting. Real-world data still shows 40-70% reduced dementia risk in GLP-1 users. The lesson isn't that GLP-1s don't help the brain. It's that timing might be everything.

Metabolic Peptides
Comparison15 min

NMN vs NR: Which NAD+ Precursor Is Better for Longevity in 2025?

A comprehensive comparison of NMN and NR—the two leading NAD+ precursors. We examine bioavailability, clinical evidence, the 2025 FDA reversal, optimal dosing, and help you determine which supplement is right for your longevity goals.

Healing & Recovery
Guide18 min

What is Triptorelin? Complete Guide to Uses, Mechanism & Safety

Comprehensive guide to triptorelin, an FDA-approved GnRH agonist. Learn about its mechanism of action, clinical uses for prostate cancer, endometriosis, precocious puberty, side effects, and how it compares to other GnRH agonists.

Healing & Recovery

Showing 10-18 of 88 articles

Jump to:
FirstPage 5Last

Looking for specific peptide data?

Browse our comprehensive peptide database with molecular information and research status.

Peptide Database